Artigos de revistas sobre o tema "UPSC"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "UPSC".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Grimm, Alexander. "Der „Ultrasound pattern sum score“ – ein möglicher Algorithmus in der Anwendung des Nervenultraschalls bei Polyneuropathien". Klinische Neurophysiologie 48, n.º 02 (18 de maio de 2017): 93–101. http://dx.doi.org/10.1055/s-0043-104917.
Texto completo da fonteGreggi, Stefano, Giorgia Mangili, Cono Scaffa, Felice Scala, Simona Losito, Francesco Iodice, Carmela Pisano et al. "Uterine Papillary Serous, Clear Cell, and Poorly Differentiated Endometrioid Carcinomas: A Comparative Study". International Journal of Gynecologic Cancer 21, n.º 4 (abril de 2011): 661–67. http://dx.doi.org/10.1097/igc.0b013e3182150c89.
Texto completo da fonteFaratian, D., A. Stillie, R. M. C. Busby-Earle, V. J. Cowie e H. Monaghan. "A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome". International Journal of Gynecologic Cancer 16, n.º 3 (2006): 972–78. http://dx.doi.org/10.1136/ijgc-00009577-200605000-00003.
Texto completo da fonteStine, Jessica E., Stuart Pierce, Paola A. Gehrig, John Nakayama, Laura Jean Havrilesky, Angeles Alvarez Secord, Wing K. Chiu, Dominic T. Moore e Kenneth H. Kim. "Recurrence rates in patients with uterine papillary serous cancer with and without breast cancer." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): e16529-e16529. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e16529.
Texto completo da fonteDörner, Marc, Mihai Ceanga, Frank Schreiber, Jan-Hendrik Stahl, Cornelius Kronlage, Julia Wittlinger, Magdalena Kramer et al. "High-Resolution Nerve Ultrasound Abnormalities in POEMS Syndrome—A Comparative Study". Diagnostics 11, n.º 2 (9 de fevereiro de 2021): 264. http://dx.doi.org/10.3390/diagnostics11020264.
Texto completo da fontede Souza, B. "Biologic behavior for patterns of recurrence and survival in ovarian versus uterine papillary serous carcinoma". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junho de 2006): 15056. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15056.
Texto completo da fonteSlomovitz, Brian M., Russell R. Broaddus, Thomas W. Burke, Nour Sneige, Pamela T. Soliman, Weiguo Wu, Charlotte C. Sun, Mark F. Munsell, David M. Gershenson e Karen H. Lu. "Her-2/neu Overexpression and Amplification in Uterine Papillary Serous Carcinoma". Journal of Clinical Oncology 22, n.º 15 (1 de agosto de 2004): 3126–32. http://dx.doi.org/10.1200/jco.2004.11.154.
Texto completo da fonteChang, W. C., B. C. Sheu, R. C. Chen, S. N. Chow e S. C. Huang. "Depressed host immunity in a case of metachronous primary uterine papillary serous carcinoma and non-Hodgkin's lymphoma". International Journal of Gynecologic Cancer 14, n.º 5 (2004): 1030–32. http://dx.doi.org/10.1136/ijgc-00009577-200409000-00043.
Texto completo da fonteShandilya, Gaurav Kumar. "Mental Health Status of UPSC CSE Aspirants: A Survey-Based Study". International Journal for Research in Applied Science and Engineering Technology 11, n.º 5 (31 de maio de 2023): 4454–58. http://dx.doi.org/10.22214/ijraset.2023.52603.
Texto completo da fonteMemarzadeh, S., C. H. Holschneider, R. E. Bristow, N. L. Jones, Y. S. Fu, B. Y. Karlan, J. S. Berek e R. Farias-Eisner. "FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival". International Journal of Gynecologic Cancer 12, n.º 5 (2002): 454–58. http://dx.doi.org/10.1136/ijgc-00009577-200209000-00008.
Texto completo da fonteElit, Laurie, Andre LaRoche, Lauren Smith, John Mazurka, Francois Moens, Jan Hauspy e Waldo Jimenez. "Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer". ISRN Obstetrics and Gynecology 2011 (11 de setembro de 2011): 1–9. http://dx.doi.org/10.5402/2011/146264.
Texto completo da fonteMcGunigal, Mary, Jerry Liu, Tamara Kalir, Manjeet Chadha e Vishal Gupta. "Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers: A National Cancer Database Analysis". International Journal of Gynecologic Cancer 27, n.º 1 (1 de janeiro de 2016): 85–92. http://dx.doi.org/10.1097/igc.0000000000000844.
Texto completo da fonteCrain, Charles Nicolas, Remy Ngwanyam e Gregory Punch. "Rare brain metastasis with unusual characteristics in a late recurrence of stage IIIA uterine papillary serous carcinoma". BJR|case reports 7, n.º 4 (julho de 2021): 20200157. http://dx.doi.org/10.1259/bjrcr.20200157.
Texto completo da fonteSeeber, Laura M. S., Ronald P. Zweemer, Luigi Marchionni, Leon F. A. G. Massuger, Vincent T. H. B. M. Smit, W. Marchien van Baal, René H. M. Verheijen e Paul J. van Diest. "Methylation profiles of endometrioid and serous endometrial cancers". Endocrine-Related Cancer 17, n.º 3 (setembro de 2010): 663–73. http://dx.doi.org/10.1677/erc-10-0014.
Texto completo da fonteSjödin, Andreas, Max Bylesjö, Oskar Skogström, Daniel Eriksson, Peter Nilsson, Patrik Rydén, Stefan Jansson e Jan Karlsson. "UPSC-BASE -Populustranscriptomics online". Plant Journal 48, n.º 5 (dezembro de 2006): 806–17. http://dx.doi.org/10.1111/j.1365-313x.2006.02920.x.
Texto completo da fontePeng, Xiangping, Shaoqing Li, Sidong Yang, Isaac Swink, Jake Carbone, Boyle Cheng e Zhanyong Wu. "Biomechanical Characterization of Unilateral and Bilateral Posterior Lumbar Interbody Fusion Constructs". BioMed Research International 2022 (13 de agosto de 2022): 1–8. http://dx.doi.org/10.1155/2022/7081238.
Texto completo da fonteHe, Jing, Rui Shi e Rimutu Ji. "Effect of Ultrasound Pre-Treatment on Extraction and Characterization of Collagen from Bactrian Camel Skin". Polymers 15, n.º 8 (19 de abril de 2023): 1943. http://dx.doi.org/10.3390/polym15081943.
Texto completo da fonteHolman, Laura L., David A. Iglesias, Pamela T. Soliman, Navdeep Pal, Ann Klopp, Russell Broaddus, Tina Ayeni et al. "Long-term survival in advanced-stage uterine papillary serous carcinoma." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 5596. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5596.
Texto completo da fonteSchmidt, Meirav, Yakir Segev, Rotem Sadeh, Erica Suzan, Ido Feferkorn, Anis Kaldawy, Gilit Kligun e Ofer Lavie. "Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma". International Journal of Gynecologic Cancer 28, n.º 7 (setembro de 2018): 1311–17. http://dx.doi.org/10.1097/igc.0000000000001300.
Texto completo da fonteVaidya, A. P., R. Littell, C. Krasner e L. R. Duska. "Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel". International Journal of Gynecologic Cancer 16, Suppl 1 (janeiro de 2006): 267–72. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00043.
Texto completo da fonteRen, Yulan, Huaying Wang, Xiaoyan Zhou, Wentao Yang, Xiaowei Huang, Yongming Lu e Daren Shi. "Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma". ISRN Obstetrics and Gynecology 2011 (20 de outubro de 2011): 1–8. http://dx.doi.org/10.5402/2011/575327.
Texto completo da fonteKato, Daniel T., Judith A. Ferry, Annekatheryn Goodman, Jana Sullinger, Robert E. Scully, A. Goff, Arlan F. Fuller e Laurel W. Rice. "Uterine Papillary Serous Carcinoma (UPSC)". Obstetrical & Gynecological Survey 51, n.º 4 (abril de 1996): 229–30. http://dx.doi.org/10.1097/00006254-199604000-00014.
Texto completo da fonteKASHIMA, K., Y. AOKI, T. YAHATA e K. TANAKA. "Complete response to docetaxel and carboplatin combination chemotherapy for a stage IV uterine papillary serous carcinoma: a case report". International Journal of Gynecologic Cancer 15, n.º 6 (novembro de 2005): 1199–202. http://dx.doi.org/10.1136/ijgc-00009577-200511000-00039.
Texto completo da fonteGupta, Divya, Marc J. Gunter, Kathleen Yang, Stephen Lee, Lisa Zuckerwise, Lee-may Chen, Gary L. Goldberg e Gloria S. Huang. "Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma". International Journal of Gynecologic Cancer 21, n.º 3 (abril de 2011): 529–34. http://dx.doi.org/10.1097/igc.0b013e31821091b5.
Texto completo da fonteTangirala, Maruthi P. "UPSC: Civil Services Examination and Beyond". Indian Journal of Public Administration 56, n.º 4 (outubro de 2010): 920–32. http://dx.doi.org/10.1177/0019556120100407.
Texto completo da fonteViswanathan, A., N. Horick, C. Tanaka, S. Campos, U. Matulonis e R. Berkowitz. "Chemotherapy and radiation therapy in UPSC". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junho de 2007): 5535. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5535.
Texto completo da fonteVillella, J. A., S. Cohen, D. H. Smith, H. Hibshoosh e D. Hershman. "HER‐2/neuoverexpression in uterine papillary serous cancers and its possible therapeutic implications". International Journal of Gynecologic Cancer 16, n.º 5 (setembro de 2006): 1897–902. http://dx.doi.org/10.1136/ijgc-00009577-200609000-00027.
Texto completo da fonteBoyraz, Gokhan, Mehmet Coskun Salman, Derman Basaran, Nejat Ozgul, Taner Turan, Osman Turkmen, Gunsu Comert Kimyon et al. "Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study". International Journal of Gynecologic Cancer 27, n.º 1 (1 de janeiro de 2016): 102–8. http://dx.doi.org/10.1097/igc.0000000000000838.
Texto completo da fonteLin, Jeff Feng-Hsu, Paniti Sukumvanich, Keila Parada, Thomas C. Krivak, Sushil Beriwal, Joseph L. Kelley e Alexander Olawaiye. "Multimodal therapy in patients with node-positive (stage IIIC) uterine papillary serous carcinoma: A National Cancer Database study." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 5585. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5585.
Texto completo da fonteLaDousa, Chaise. "Language medium and a high-stakes test: Language ideology and coaching centers in North India". International Journal of the Sociology of Language 2018, n.º 253 (28 de agosto de 2018): 103–24. http://dx.doi.org/10.1515/ijsl-2018-0025.
Texto completo da fonteSteed, H., L. Manchul, B. Rosen, A. Fyles, G. Lockwood, S. Laframboise, J. Murphy, M. Milosevic, W. Chapman e A. M. Oza. "Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy". International Journal of Gynecologic Cancer 16, Suppl 1 (janeiro de 2006): 278–85. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00045.
Texto completo da fonteSemer, D., N. P. Nguyen, S. Sallah, U. Karlsson, P. Vos, A. Ludin, D. Tait, M. Salehpour, G. Jendrasiak e C. Robiou. "Prognosis for papillary serous carcinoma of the endometrium after surgical staging". International Journal of Gynecologic Cancer 11, n.º 4 (2001): 305–11. http://dx.doi.org/10.1136/ijgc-00009577-200107000-00009.
Texto completo da fonteRoelofsen, Thijs, Marjanka Mingels, Jan C. M. Hendriks, Rahul A. Samlal, Marc P. Snijders, Anette L. Aalders, Johan Bulten, Maaike A. P. C. Van Ham e Leon F. A. G. Massuger. "Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients". International Journal of Biological Markers 27, n.º 3 (julho de 2012): 263–71. http://dx.doi.org/10.5301/jbm.2012.9346.
Texto completo da fonteHoang, Nhat-Duc, Duy-Thang Vu, Xuan-Linh Tran e Van-Duc Tran. "Modeling Punching Shear Capacity of Fiber-Reinforced Polymer Concrete Slabs: A Comparative Study of Instance-Based and Neural Network Learning". Applied Computational Intelligence and Soft Computing 2017 (2017): 1–11. http://dx.doi.org/10.1155/2017/9897078.
Texto completo da fonteBaek, Min-Hyun, Shin-Wha Lee, Jeong-Yeol Park, Daeyeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim e Joo-Hyun Nam. "Identification of a Preoperative Predictive Factor for Lymph Node Metastasis in Uterine Papillary Serous Carcinoma: Long-term Results From a Single Institution". International Journal of Gynecologic Cancer 25, n.º 1 (janeiro de 2015): 69–74. http://dx.doi.org/10.1097/igc.0000000000000318.
Texto completo da fonteHong, Julian C., Jonathan Foote, Gloria Broadwater, Stéphanie Gaillard, Laura J. Havrilesky e Junzo P. Chino. "Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus". International Journal of Gynecologic Cancer 27, n.º 4 (maio de 2017): 720–29. http://dx.doi.org/10.1097/igc.0000000000000926.
Texto completo da fonteGrowdon, Whitfield B., J. Jose A. Rauh-Hain, Adriana Cordon, Leslie Garrett, John O. Schorge, Annekathryn Goodman, David M. Boruta, Neil S. Horowitz e Marcela G. del Carmen. "Prognostic Determinants in Patients With Stage I Uterine Papillary Serous Carcinoma: A 15-Year Multi-Institutional Review". International Journal of Gynecologic Cancer 22, n.º 3 (março de 2012): 417–24. http://dx.doi.org/10.1097/igc.0b013e31823c6e36.
Texto completo da fonteHuh, W. K. "What is the correct management of stage i UPSC?" International Journal of Gynecological Cancer 15, n.º 2 (março de 2005): 405–6. http://dx.doi.org/10.1111/j.1525-1438.2005.abst_13.x.
Texto completo da fonteHamilton, C. A., M. M. Zhang, J. K. Chan, M. K. Cheung, S. H. Thorne, J. Baker, C. H. Contag e R. S. Negrin. "A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junho de 2006): 15044. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15044.
Texto completo da fonteHuh, W. K. "WHAT IS THE CORRECT MANAGEMENT OF STAGE I UPSC?: 0013". International Journal of Gynecologic Cancer 15, n.º 2 (2005): 405.3–406. http://dx.doi.org/10.1136/ijgc-00009577-200503000-00049.
Texto completo da fonteBracchiglione, Javier, Gerardo Rodríguez-Grijalva, Carolina Requeijo, Marilina Santero, Josefina Salazar, Karla Salas-Gama, Adriana-Gabriela Meade et al. "Systemic Oncological Treatments versus Supportive Care for Patients with Advanced Hepatobiliary Cancers: An Overview of Systematic Reviews". Cancers 15, n.º 3 (26 de janeiro de 2023): 766. http://dx.doi.org/10.3390/cancers15030766.
Texto completo da fonteChambers, J. T., M. Merino, E. I. Kohorn, P. E. Peschel e P. E. Schwartz. "Uterine papillary serous carcinoma (UPSC) at Yale-New Haven Hospital (YNHH)". Gynecologic Oncology 23, n.º 2 (fevereiro de 1986): 262. http://dx.doi.org/10.1016/0090-8258(86)90277-5.
Texto completo da fonteKato, Daniel T., Judith A. Ferry, Annekathryn Goodman, Jana Sullinger, Robert E. Scully, Barbara A. Goff, Arlan F. Fuller, Jr. e Laurel W. Rice. "Uterine Papillary Serous Carcinoma (UPSC): A Clinicopathologic Study of 30 Cases". Gynecologic Oncology 59, n.º 3 (dezembro de 1995): 384–89. http://dx.doi.org/10.1006/gyno.1995.9957.
Texto completo da fonteGadducci, Angiolo, Stefania Cosio, Fabio Landoni, Tiziano Maggino, Paolo Zola, Luca Fuso e Enrico Sartori. "Analysis of Treatment Failures and Survival of Patients With Uterine Papillary Serous Carcinoma: A Cooperation Task Force (CTF) Study". International Journal of Gynecologic Cancer 22, n.º 8 (outubro de 2012): 1355–60. http://dx.doi.org/10.1097/igc.0b013e318267f7a0.
Texto completo da fonteChoquejahua Olivera, Lizbet, Nilda Mabel Flores Chavez, Soledad Jackeline Zegarra Ugarte, Yolanda Pari Ccama, Jorge Lucio Onofre Chura e Javier David Olivera Chura. "Clima organizacional y su relación con el desempeño laboral de los trabajadores administrativos de la universidad privada San Carlos 2020". Llamkasun 4, n.º 2 (26 de dezembro de 2022): 24–36. http://dx.doi.org/10.47797/llamkasun.v4i2.122.
Texto completo da fonteLa Fianza, Alfredo, Elisa Alberici, Enrico Maria Di Maggio, Lorenzo Preda e Rodolfo Campani. "Multiple nodular metastases in mesenteric panniculitis by uterine papillary serous adenocarcinoma (upsc):". Clinical Imaging 23, n.º 2 (março de 1999): 90–93. http://dx.doi.org/10.1016/s0899-7071(98)00092-8.
Texto completo da fonteSlomovitz, Brian M., Thomas W. Burke, Patricia J. Eifel, Lois M. Ramondetta, Elvio G. Silva, Anuja Jhingran, Jonathan C. Oh et al. "Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases". Gynecologic Oncology 91, n.º 3 (dezembro de 2003): 463–69. http://dx.doi.org/10.1016/j.ygyno.2003.08.018.
Texto completo da fonteFader, Amanda Nickles, David Starks, Paola A. Gehrig, Angeles Alvarez Secord, Heidi E. Frasure, David M. O'Malley, Erin R. Tuller et al. "An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)". Gynecologic Oncology 115, n.º 2 (novembro de 2009): 244–48. http://dx.doi.org/10.1016/j.ygyno.2009.07.030.
Texto completo da fonteLevenback, C., T. Burke, E. Silva, M. Morris, D. Gershenson, J. Kavanagh e J. T. Wharton. "Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)". Gynecologic Oncology 40, n.º 2 (fevereiro de 1991): 191–92. http://dx.doi.org/10.1016/0090-8258(91)90215-q.
Texto completo da fonteLev́enback, Charles, Thomas W. Burke, Elvio Silva, Mitchell Morris, David M. Gershenson, John J. Kavanagh e J. Taylor Wharton. "Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)". Gynecologic Oncology 46, n.º 3 (setembro de 1992): 317–21. http://dx.doi.org/10.1016/0090-8258(92)90224-7.
Texto completo da fonte